Corvus Pharmaceuticals Inc (CRVS) Stock Price, Quote, News & History

CRVSNASDAQ
$16.07
0.050.31%
Last update: Apr 24, 9:30 AM
Earnings: Q1 2026 Earnings in 13 days from now on Thu May 7th, after the market close

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-32.80M
Investing Cash Flow (TTM)
-7.80M
Financing Cash Flow (TTM)
36.43M
Free Cash Flow (TTM)
-32.97M
Capital Expenditure (TTM)
-174.00K
Net Change in Cash (TTM)
-4.16M

Analyst Trends and Forecast

4
Jan
1
Mar
1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.29B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
21.97
Earnings Yield % (TTM)
-3.31%
Earnings Yield % (FWD)
-3.90%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.73

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$4.58M
Debt to Equity
0.02
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$16.01
Close
-
Volume / Avg.
508.38K / 1.59M
Day Range
$15.31 - $16.45
52 Wk Range
3.17 - 26.95
Market Cap
$1.35B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
24.79%
Days to Cover
11.09

About

Sector
Health Care
Industry
Biotechnology
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Corvus Pharmaceuticals (CRVS) stock?

A

You can purchase shares of Corvus Pharmaceuticals (NASDAQ:CRVS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Corvus Pharmaceuticals (CRVS) competitors?

Q

What is the forecast, or price target, for Corvus Pharmaceuticals (CRVS) stock?

A

Corvus Pharmaceuticals has a consensus price target of $25.69.

Q

What is the current price for Corvus Pharmaceuticals (CRVS)?

A

The stock price for Corvus Pharmaceuticals (NASDAQ: CRVS) is $16.07 last updated April 24, 2026 at 9:30 AM EDT.

Q

Does Corvus Pharmaceuticals (CRVS) pay a dividend?

A

There are no upcoming dividends for Corvus Pharmaceuticals.

Q

When is Corvus Pharmaceuticals (NASDAQ:CRVS) reporting earnings?

A

Corvus Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Corvus Pharmaceuticals (CRVS) going to split?

A

There is no upcoming split for Corvus Pharmaceuticals.

Q

What sector and industry does Corvus Pharmaceuticals (CRVS) operate in?

A

Corvus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.